Stephen G. Machatha
Chief Development Officer
Other
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Aldeyra Therapeutics, Inc. (ALDX) | Ph.D. . Chief Development Officer | $400,000 | $1,452,142 |
| 2024 | Aldeyra Therapeutics, Inc. (ALDX) | Chief Development Officer | $392,340 | $1,688,381 |
| 2023 | Aldeyra Therapeutics, Inc. (ALDX) | Chief Development Officer | $377,250 | $1,593,108 |
| 2022 | Aldeyra Therapeutics, Inc. (ALDX) | Chief Development Officer | $359,287 | $2,565,216 |
| 2021 | Aldeyra Therapeutics, Inc. (ALDX) | Chief Development Officer | $333,572 | $1,431,416 |
Executive changes
Earnings-call appearances
No earnings-call appearances recorded yet.